MDU Resources Group Inc. Common Stock (Holding Company) vs Roivant Sciences Ltd. Common Shares — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while Roivant Sciences Ltd. Common Shares trades at $33.62 (market cap $24.99B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6.4× MDU Resources Group Inc. Common Stock (Holding Company)'s market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.03% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Roivant Sciences Ltd. Common Shares for 3 Days on average.
| MDU | ROIV | |
|---|---|---|
Market Cap | $3.92B | $24.99B |
Volume | 1,027,656 | 4,711,562 |
Sector | Utilities | Health |
52-Week High | $22.80 | $41.81 |
52-Week Low | $18.39 | $16.99 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $6.45B | $21.25B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Roivant Sciences (ROIV) trades at $33.35, down 3.58% on the day amid a bearish technical signal. The stock faces fundamental headwinds with a net loss of $172 million in 2025 and negative cash flow, though recent news highlights pipeline progress including positive Phase 2 data for mosliciguat in PH-ILD. Analyst sentiment remains strongly bullish with a consensus price target of $46.75.
The outlook hinges on clinical execution; upside exists if pipeline assets like LISRAYA launch successfully, but high cash burn and profitability challenges pose significant risks. Near-term price action is pressured, but long-term value depends on converting R&D into commercial success.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →